Paxman AB (publ), together with its subsidiaries, provides cryotherapy solutions in the United Kingdom, Europe, North and South America, Oceania, and Asia. The company offers Paxman scalp cooling system, a mechanized form of scalp cooling for the prevention of chemotherapy-induced alopecia. It also engages in the development of a medical cryocompression device for the prevention of chemotherapy-induced peripheral neuropathy. The company was founded in 1996 and is based in Karlshamn, Sweden.
Frequently asked questions
What sector does Paxman AB (PAX) operate in?
Paxman AB belongs to the Healthcare sector and operates in the Medical Devices industry.
What is Paxman AB (PAX) current stock price?
As of the latest data, Paxman AB stock price is SEK 44.50, with a previous close of SEK 45.00. Paxman AB lost -SEK 0.50 in the last trading session, representing a -1.11% loss.
What is Paxman AB (PAX) current market capitalization?
Paxman AB market cap is approximately 1.04 billion.
What is Paxman AB (PAX) Earnings Per Share (EPS)?
The trailing EPS is -SEK 0.47, and the forward EPS is SEK 4.13.
What is Paxman AB (PAX) EBITDA?
Paxman AB EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 10.54 million.
Does Paxman AB (PAX) pay dividends?
No. Paxman AB does not pay a dividend.
How did Paxman AB (PAX) perform in its most recent earnings report?
In the last report (March 31, 2026), Paxman AB posted an EPS surprise of 120% and a revenue surprise of 1.25%.
What is Paxman AB (PAX) beta (volatility) score?
Paxman AB has a beta of 0.462, indicating lower volatility than the overall market.
